Highly topographic organization of neural circuits exists for the regulation of various brain functions in corticobasal ganglia circuits. Although neural circuit-specific refinement during synapse development is essential for the execution of particular neural functions, the molecular and cellular mechanisms for synapse refinement are largely unknown. Here, we show that protocadherin 17 (PCDH17), one of the nonclustered d2-protocadherin family members, is enriched along corticobasal ganglia synapses in a zone-specific manner during synaptogenesis and regulates presynaptic assembly in these synapses. PCDH17 deficiency in mice causes facilitated presynaptic vesicle accumulation and enhanced synaptic transmission efficacy in corticobasal ganglia circuits. Furthermore, PCDH17 À/À mice exhibit antidepressant-like phenotypes that are known to be regulated by corticobasal ganglia circuits. Our findings demonstrate a critical role for PCDH17 in the synaptic development of specific corticobasal ganglia circuits and suggest the involvement of PCDH17 in such circuits in depressive behaviors.
INTRODUCTION
The basal ganglia comprise a group of subcortical nuclei that includes the striatum, the globus pallidus, and the substantia nigra. These nuclei receive input from the cerebral cortex and send output to the thalamus, constituting corticobasal gangliathalamocortical loops that govern various brain functions associated with complex motor action, reward-based learning, cognition, emotion, and motivation (Redgrave et al., 2010; Utter and Basso, 2008) . To perform these different functions, individual cortical areas project to discrete regions of the basal ganglia in a highly topographic manner (Alexander and Crutcher, 1990; Redgrave et al., 2010) . Thus, prefrontal cortical areas provide input to anterior regions of the striatum; sensorimotor cortical areas project to central dorsolateral regions; and the parietal cortex provides input to more posterior regions (Draganski et al., 2008; Takada et al., 2001; Wiesendanger et al., 2004) . Dysfunctions along the corticobasal ganglia circuit lead to neurological and neuropsychiatric diseases, including Parkinson's disease, obsessive-compulsive disorder, schizophrenia, and depressive disorder (Krishnan and Nestler, 2008; Simpson et al., 2010; Utter and Basso, 2008) . Therefore, clarification of the precise topography and pathway-specific synapse development in corticobasal ganglia circuits is crucial for understanding the mechanisms that regulate respective brain functions.
The anatomical topography of neural circuits generally emphasizes distinct functional units. Functional establishment of this topography requires circuit-specific differentiation and refinement of synapses. Recent studies suggest that synapse development in individual circuits is organized by various types of synaptic interaction molecules (Williams et al., 2010) . Proteins of the cadherin superfamily, including the protocadherin family, are thought to participate in synapse-specific interactions (Shapiro and Colman, 1999; Williams et al., 2011; Zipursky and Sanes, 2010) . This family of proteins is expressed in synaptic junctions between different types of neurons in neural circuits (Kim et al., 2007; Redies, 2000) . Owing to their highly selective adhesive interactions, cadherin-catenin complexes are required for both pre-and postsynaptic development (Arikkath and Reichardt, 2008; Togashi et al., 2002) . Although some cadherin members are expressed in specific zones of the basal ganglia (Hertel et al., 2008) , their roles in circuitspecific synaptic development and their physiological significance remain unclear.
After enormous numbers of synapses are formed, subsequent synaptic refinement is an essential step for the completion of functional neural circuits. Recently, molecular mechanisms that control recruitment and localization of synaptic vesicles (SVs) to presynaptic locations have attracted much attention (Goda and Davis, 2003; Ziv and Garner 2004) . Furthermore, dynamic regulation of presynaptic SV by neural activity is thought to be a fundamental process involved in presynaptic plasticity (Hopf et al., 2002; Regehr, 2012) . Several lines of evidence suggest that trans-synaptic cell adhesion molecules, such as cadherin superfamily proteins, SynCAM family proteins, and the neurexin-neuroligin complex, help trigger presynaptic assembly (Ziv and Garner, 2004) . Ablation of N-cadherin or b-catenin in neurons results in reduced SV assembly in presynaptic terminals (Bamji et al., 2003; Stan et al., 2010) , suggesting that cadherincatenin adhesive complexes play a pivotal role in localizing SVs to presynaptic compartments (Arikkath and Reichardt, 2008) . Although some protocadherins are thought to participate in presynaptic assembly, roles of individual protocadherin members in vivo in synapse refinement and function are not well understood.
In the present study, we addressed the biological significance of PCDH17, a nonclustered d2-protocadehrin family member. Our results indicate that PCDH17 plays a crucial role in the regulation of presynaptic vesicle assembly in corticobasal ganglia circuits. Furthermore, PCDH17 deficiency leads to altered presynaptic function in the corticostriatal pathway. We also observed antidepressant-like phenotypes in PCDH17 À/À mice.
These results provide new insights into the mechanisms underlying the synaptic development of specific corticobasal ganglia circuits and the physiological role of depression-related behaviors.
RESULTS

PCDH17 Is Expressed along Corticobasal Ganglia
Circuits in a Topographic Manner PCDH17, a member of the nonclustered d2-protocadherin family, is a transmembrane protein that displays the six extracellular cadherin domains and two cytoplasmic motifs, CM1 and CM2, that are conserved in this family (Redies et al., 2005 ; Figure 1A ). Immunoblot analysis showed that mouse PCDH17 is specifically expressed in the brain ( Figure 1B) and that its expression level is high during early synaptogenesis (postnatal weeks 1-2) ( Figure 1C ). At postnatal day 10, immunohistochemistry revealed that PCDH17 is distributed in the striatum, lateral globus pallidus (LGP), medial globus pallidus (MGP), and substantia nigra pars reticulata (SNr) of the basal ganglia in a highly zone-specific manner ( Figure 1D ). To precisely evaluate the expression pattern of PCDH17 in basal ganglia, we co-stained PCDH17 and DARPP-32, which are expressed in striatal medium spiny neurons (MSNs) and which are distributed in almost all basal ganglia nuclei. It was found that PCDH17 is distributed in anterior regions of the striatum, including the anterior dorsal striatum and the anterior nucleus accumbens, inner regions of the LGP and MGP, and posterior regions of the SNr ( Figure 1E and see Figure S1A available online). To characterize PCDH17-expressing cells along the corticobasal ganglia circuits, we performed X-gal staining of brain slices from PCDH17 heterozygous mice expressing LacZ under control of the PCDH17 promoter ( Figure S3A ). b-gal-positive neurons were localized in the anterior striatum, inner LGP, inner MGP, and posterior SNr. This staining pattern is virtually identical to that observed with PCDH17 antibody (Figures 1F and S1B ). Costaining of b-gal and DARPP-32 revealed that anterior striatal MSNs express PCDH17 (data not shown). b-gal-positive neurons were also identified in the cerebral cortex; The b-gal signal was strongest in the medial prefrontal cortex, high in the cingulate cortex and motor cortex, and moderate to low in the somatosensory cortex and posterior part of the cortex ( Figures 1G and S1B ).
In addition, the b-gal signal was strong in layer V neurons, including those that project to MSNs (Figures 1G and S1B), although it was also strongly expressed in layer II/III neurons of the medial prefrontal cortex. We next investigated whether PCDH17-expressing regions were anatomically connected in the corticobasal ganglia pathway using the fluorescent neuronal tracer, cholera toxin subunit B (CTb) conjugated to Alexa Fluor 488. When CTb was injected into the anterior striatum for retrograde tracing, medial prefrontal cortical neurons were mostly labeled ( Figure S1C ). CTb can also be used for anterograde tracing (Angelucci et al., 1996) . Accordingly, double fluorescence histochemistry with CTb and immunostained PCDH17 showed that CTb anterograde-labeled anterior striatal axon terminals accurately identify PCDH17-positive zones in basal ganglia ( Figure S1D ). In addition, the Gene Expression Nervous System Atlas (GENSAT) database (http://www.gensat.org/ index.html) contains PCDH17 promoter-driven EGFP-expressing transgenic mice. Their EGFP expression patterns are similar to PCDH17 expression patterns in basal ganglia, reflecting PCDH17-expressing pathways ( Figure S1E ). Overall, PCDH17 was expressed at the high level in both pre-and postsynaptic neurons in the medial prefrontal cortex and anterior striatum, as well as the inner LGP, inner MGP, and posterior SNr. In other words, PCDH17 is expressed along the anatomically connected corticobasal ganglia pathways in a highly topographic manner.
Complementary Expression Patterns of PCDH17 and PCDH10 in Corticobasal Ganglia Circuits Because protocadherin 10 (PCDH10), another d2-protocadherin family member, is highly expressed in the striatum (Aoki et al., 2003) , we next compared expression patterns of both of these proteins in basal ganglia. Double immunostaining of PCDH17 and PCDH10 showed that while PCDH17 is distributed in the anterior striatum, PCDH10 is distributed in the posterior striatum ( Figure 2A ). Therefore, expression of the two protocadherins was complementary along the anteroposterior axis. Their distributions are also complementary in the LGP and MGP; PCDH17 displays an inner distribution, but PCDH10 displays an outer distribution within these regions ( Figure 2A ). Furthermore, in contrast to the distribution of PCDH17 in the posterior SNr, PCDH10 is distributed in the anterior SNr ( Figure 2A ). Doublefluorescent in situ hybridization demonstrated that both PCDH17 and PCDH10 mRNAs also exhibit complementary expression patterns in basal ganglia ( Figure S2 ). Thus, these findings indicate that PCDH17 and PCDH10 delineate topographic features of this pathway.
We next compared the protein expression patterns of PCDH17 and PCDH10 in the cerebral cortex and thalamus, particularly in the prefrontal cortex and the mediodorsal thalamus, as these regions are anatomically and functionally incorporated into the corticobasal ganglia-thalamocortical loops (McCracken and Grace, 2009; McFarland and Haber, 2002) . In the prefrontal cortex, while PCDH17 is distributed in the medial prefrontal cortex, PCDH10 expression is higher in the orbitofrontal cortex, indicating partially complementary expression patterns ( Figure 2B ). In subregions of the mediodorsal thalamus, PCDH17 and PCDH10 expression are also expressed in a somewhat complementary manner ( Figure 2C ). Thus, expression of LGP, lateral globus pallidus; MGP, medial globus pallidus; mPFC, medial prefrontal cortex; M1, primary motor cortex; M2, secondary motor cortex; NA, nucleus accumbens; Ob, olfactory bulb; SNr, substantia nigra pars reticulata; Str, striatum; S1, primary somatosensory cortex. See also Figure S1 .
PCDH17 and PCDH10 are largely complementary throughout the corticobasal ganglia-thalamocortical loop circuits in a highly topographic manner. We note that expression of PCDH17 and PCDH10 partially overlaps in some cortical and thalamic areas, which could explain the presence of integrative and converging trans-circuits in these areas (Draganski et al., 2008) .
PCDH17 Is Localized at Perisynaptic Sites in Basal Ganglia
We examined the subcellular localization of PCDH17 in basal ganglia using high-resolution structured illumination microscopy (SIM) to acquire 3D images with resolution approaching 100 nm (Schermelleh et al., 2008) . We performed immunostaining of PCDH17 in addition to VGLUT1 and PSD-95, markers of the pre-and postsynaptic compartments of corticostriatal excitatory synapses, respectively. SIM images of the anterior striatum revealed that PCDH17 proteins are present in punctate structures, a subset of which is associated with VGLUT1 and PSD-95 (Figure 3A) . 3D reconstructed images showed that PCDH17 is localized next to juxtaposed pairs of VGLUT1 and PSD-95 ( Figure 3A ). Using stochastic optical reconstruction microscopy (STORM),
another new, super-resolution imaging technique, distributions of synaptic proteins can be measured with nanometer precision (Dani et al., 2010) . Two-color 2D STORM images clearly resolved the PCDH17/VGLUT1 protein distribution and the PCDH17/ PSD-95 protein distribution as adjacent, but discrete molecular structures ( Figure 3B ). We next used pre-embedding immunogold electron microscopy to analyze PCDH17 ultrastructural localization in asymmetric synapses of MSNs, most of which are thought to be corticostriatal excitatory synapses (Surmeier, et al., 2007) . In MSNs of the anterior striatum, immunogold particles indicating PCDH17 localization were observed in presynaptic boutons, dendritic shafts, and dendritic spines, where the majority of particles were attached to the plasma membrane ( Figures 3C and 3D ). To quantify the distribution of PCDH17 at synapses in detail, we divided each synapse cross-section into central, peripheral, perisynaptic, and extrasynaptic regions, and scored each region for immunogold particles (Nakazawa et al., 2006) . Many of the membrane-associated particles were perisynaptically localized at both pre-and postsynaptic sites in an apposed manner ( Figures 3C and 3D ). Furthermore, in the inner regions of the LGP, 3D-SIM imaging revealed that PCDH17 LGP, lateral globus pallidus; LHb, lateral habenula; LMD, lateral mediodorsal thalamus; MGP, medial globus pallidus; MHb, medial habenula; MMD, medial mediodorsal thalamus; mPFC, medial prefrontal cortex; M2, secondary motor cortex; OFC, orbitofrontal cortex; PC, paracentral thalamic nucleus; PV, paraventricular thalamic nucleus; SNr, substantia nigra pars reticulata. See also Figure S2 .
puncta are associated with VGAT and gephyrin, markers of the pre-and postsynaptic compartments of striatopallidal inhibitory synapses, respectively ( Figure 3E ). STORM imaging also clearly resolved the PCDH17/VGAT protein distribution and the PCDH17/gephyrin protein distribution as neighboring molecular structures ( Figure 3F) . At the ultrastructural level, PCDH17 particles were mostly located at perisynaptic sites in inhibitory symmetric synapses ( Figures 3G and 3H ). These findings indicate that PCDH17 is localized in both excitatory and inhibitory perisynaptic sites in basal ganglia nuclei.
PCDH17-Mediated Intercellular Homophilic Interaction
Given that most cadherin family members exhibit calciumdependent homophilic interactions, we then investigated PCDH17-mediated homophilic interactions using biochemical assays. We prepared a soluble form of the Fc-fused extracellular domain of PCDH17 (PCDH17E-Fc) with independently prepared myc-tagged, full-length PCDH17 (PCDH17-myc) at various Ca 2+ concentrations ( Figure 4A ). Immunoblotting revealed that PCDH17E-Fc interacted with PCDH17-myc in solutions at Ca 2+ concentration >1 mM ( Figure 4B ). This interaction was abolished in the presence of the calcium chelator, EDTA, further supporting the conclusion that the observed homophilic binding is calcium-dependent ( Figure 4B ). Furthermore, PCDH17 did not exhibit heterophilic interactions with PCDH10 ( Figure 4C ). The specificity of intercellular interactions of PCDH17 was also examined using CHO cells stably expressing PCDH17 or PCDH10. In a coculture system with these stable cell lines, PCDH17 was localized at contact sites between PCDH17-expressing cells, but not at contact sites with cells expressing PCDH10 ( Figure 4D ). In addition, we also performed coculture experiments between cortical neurons expressing PCDH17-EGFP and CHO cells expressing either PCDH17-myc or PCDH10-myc. A significant portion of PCDH17-EGFP in neurons was localized next to PCDH17-myc in CHO cells at contact points, but not PCDH10-myc in CHO cells ( Figure 4E ). Taking these results together with the finding that PCDH17 is mainly localized at both excitatory and inhibitory perisynaptic sites (Figure 3 ), we conclude that PCDH17 mediates homophilic intercellular interactions at synapses in basal ganglia ( Figure 4F ).
PCDH17 -/-Mice Show Increased Numbers of Synaptic Vesicles at Presynaptic Terminals in Zone-Specific Basal Ganglia Pathways
To examine the physiological role of PCDH17, we generated PCDH17 À/À mice ( Figure S3A ). The success of the procedure was confirmed by Southern blot (data not shown) and PCR analysis ( Figure S3B ). We confirmed the absence of the PCDH17 protein in PCDH17 À/À mice by immunoblotting and immunostaining ( Figures S3C and S3D ). The loss of PCDH17 in PCDH17 À/À mice was also confirmed by immunoelectron microscopy ( Figure S3E ). Quantitative analysis in the anterior striatum verified a 96% reduction in numbers of immunogold particles in comparison with wild-type mice. The numbers of PCDH17 À/À mice produced followed a Mendelian segregation pattern and these mice attained normal body size and appeared healthy (data not shown). Histological analysis using Nissl-stained coronal sections from the central nervous system from PCDH17 À/À mice did not show any gross abnormalities in cytoarchitecture ( Figure S3F ). In addition, the absence of PCDH17 did not affect the expression of synapse-specific markers, including N-cadherin, Synaptophysin, VGLUT1, PSD-95, NMDA receptor subunits, and AMPA receptor subunits in the anterior and posterior striatum ( Figure S3G ). We examined whether axonal projections were abrogated in the absence of PCDH17. Immunostaining analyses showed that PCDH17 deficiency did not affect overall axonal projections, including corticothalamic/thalamocortical projections, striatopallidal/striatonigral projections, and nigrostriatal projections ( Figures S4A and S4B) . Therefore, in contrast to the abnormal axonal projection phenotypes observed in PCDH10 À/À mice (Uemura et al., 2007) , the overall circuitry in basal ganglia appeared to be intact in PCDH17 À/À mice.
We next evaluated whether ablation of PCDH17 affected the topographic connections within the corticobasal ganglia circuits. In retrograde tracing, local injections of CTb-Alexa Fluor 488 into the anterior striatum and CTb-Alexa Fluor 555 into the posterior striatum resulted in the labeled signals in medial prefronatal cortex and motor cortex, respectively, in both wild-type and PCDH17 À/À mice ( Figure S4C ). Thus, PCDH17 deficiency did not affect projection topography in corticostriatal pathways. Anterograde tracing using CTb-Alexa Fluor 488 revealed no defects of projection topography of PCDH17 À/À striatal axons onto output nuclei ( Figure S4D ).
We also found that the PCDH10 expression pattern and PCDH17 promoter-driven b-gal pattern were unaffected in basal ganglia ( Figures S4E and S4F ). These findings strongly suggested that PCDH17 is not involved in topographic map formation along corticobasal ganglia circuits. We then performed electron microscopic analysis of synaptic morphology in 3-week-old wild-type and PCDH17 À/À mice.
In excitatory asymmetric synapses of the anterior striatum, where PCDH17 expression was evident, PCDH17 deficiency caused significant increases in the number of docked SVs and the total number of SVs per presynaptic terminal, whereas in the posterior striatum where PCDH17 expression was weak, these parameters did not exhibit significant changes ( Figures  5A and 5B). Other parameters, such as average postsynaptic spine area, PSD length, synaptic cleft width, and the density of asymmetric synapses, were similar in wild-type and PCDH17 À/À sections ( Figures 5B and 5C ). We also investigated inhibitory symmetric synapses of the LGP as output nuclei from the striatum. Increased numbers of docked SVs and total SVs per presynaptic terminal were observed in the inner LGP, but not in the outer LGP after PCDH17 ablation ( Figures 5D  and 5E ). Synaptic cleft width and density of symmetric synapses were similar in both zones ( Figures 5E and 5F ). There were no changes in synapse densities ( Figures 5C and 5F ) or the expression of presynaptic proteins in PCDH17 À/À mice (Figure S3E) . Only an increased number of docked SVs and total SVs per presynaptic terminal were observed in PCDH17
neurons. Taken together, PCDH17 appears to regulate presynaptic SV assembly at both excitatory synapses on MSNs and inhibitory synapses on LGP neurons in each zone-specific region. (legend continued on next page)
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Overexpression of PCDH17 Results in Diffusion of Synaptic Vesicle Puncta and Increases Mobility of Presynaptic Clusters in Cultured Cortical Neurons
To evaluate the role of PCDH17 in SV assembly in vitro, we overexpressed PCDH17 in cultured cortical neurons in concert with synaptophysin-EGFP (Syn-EGFP), which is an SV marker used to monitor SV assembly (Bamji et al., 2003) . In the axons of control cells, Syn-EGFP exhibited rounded, punctate clusters. In contrast, Syn-EGFP puncta that were originally associated with PCDH17 puncta became more diffuse in PCDH17-overexpressing neurons ( Figures S5A and S5B ), suggesting that expression of PCDH17 inhibits the accumulation of SVs. Because inhibition of SV assembly to the presynaptic terminal promotes SV cluster movements (Bamji et al., 2003) , we examined whether overexpression of PCDH17 affected the mobility of SV clusters. While Syn-EGFP large puncta were stable or slow-moving in control axons, Syn-EGFP large puncta were relatively mobile and exhibited coordinated movement with PCDH17-mCherry puncta in PCDH17-overexpressing axons (Figures S5C-S5E ; Movies S1 and S2). These findings demonstrate that PCDH17 clusters are mobile elements and that PCDH17 overexpression promotes the mobility of SV clusters along axons.
PCDH17 -/-Mice Exhibit Altered Synaptic Transmission Efficacy at Corticoanterior Striatal Synapses
To further characterize the role of PCDH17 in synaptic function, we performed electrophysiological analysis of corticostriatal synapses in acute slices. Since MSNs in the anterior portion of the striatum strongly express PCDH17 ( Figures 1D and 1E ), we made whole-cell recordings from MSNs in the anterior striatum in wild-type and PCDH17 À/À mice of about three weeks of age.
To assess spontaneous synaptic transmission, we measured miniature excitatory postsynaptic current (mEPSC). Both the frequency and amplitude of mEPSCs in PCDH17 À/À MSNs were comparable to those in wild-type MSNs ( Figure 6A ), suggesting that the number of functional synapses is not altered in the absence of PCDH17. We next analyzed the AMPA and NMDA receptor-mediated components of evoked EPSCs. No significant differences were observed in the 10%-90% rise time and the decay time constant of either the AMPA or NMDA receptor-mediated EPSCs between wild-type and PCDH17 À/À mice ( Figure S6A ). Furthermore, the AMPA/NMDA ratio was not altered in PCDH17 À/À mice, compared to wild-type mice (Figure 6B) . These results indicate that basic properties of AMPA and NMDA receptors at corticostriatal synapses and their relative contributions to corticostriatal synaptic transmission are not altered in PCDH17 À/À mice.
To examine possible presynaptic changes in PCDH17 À/À mice, we next analyzed the paired-pulse ratio of evoked AMPA receptor-mediated EPSCs at a range of interstimulus intervals. We observed that the paired-pulse ratio exhibited a tendency to increase in PCDH17 À/À mice ( Figure 6C ). These results would suggest that PCDH17 deficiency may affect presynaptic function at corticostriatal synapses. However, post-hoc tests did not reveal significant difference between genotypes at any pulse interval. To test whether presynaptic function of GABAergic inhibitory synapses was altered in PCDH17 À/À mice, we analyzed the paired-pulse ratio of evoked inhibitory postsynaptic currents (IPSCs) at anterior striatal-LGP synapses. We made whole-cell recordings from neurons in the inner portion of the LGP where PCDH17 was strongly expressed (Figures 1D and 1E ) and stimulated the corresponding portion of the anterior striatum. We found that the paired-pulse ratio of IPSCs was significantly increased in PCDH17 À/À mice at inter-pulse interval of 50 ms ( Figure S6B ), although basic properties of GABA receptors were not changed ( Figure S6A ). Taken together, these results suggest that PCDH17 would be important for the presynaptic function in both excitatory and inhibitory synapses in the basal ganglia. We then assessed the recycling process of SVs in presynaptic terminals by measuring synaptic depression induced by prolonged repetitive stimulation. Synaptic depression is reported to reflect a presynaptic cycling process in which depleted docked vesicles are replenished by reserve pool vesicles (Bamji et al., 2003; Cabin et al., 2002) . We applied repetitive stimulation (10 Hz, 200 pulses) to corticostriatal fibers and measured the amplitude of AMPA receptor-mediated EPSCs relative to that of the first response ( Figure 6D ). Since repetitive stimulation can release endocannabinoid 2-arachidonoyl glycerol from MSNs (Kano et al., 2009; Maejima et al., 2005) , we applied a cannabinoid CB 1 receptor antagonist to block the endocannabinoid-mediated retrograde suppression of corticostriatal synapses and to evaluate unadulterated presynaptic function. In wild-type and PCDH17 À/À mice at P21-P23, the normalized EPSC amplitude decreased gradually during prolonged repetitive stimulation, but the depression of the normalized EPSC amplitude was significantly weaker in PCDH17 À/À mice ( Figure 6D ). There was no significant difference in average amplitudes of the first ten EPSCs between wild-type and PCDH17 À/À mice ( Figure S6A ). Since the numbers of total SVs was increased in PCDH17 À/À synapses at three weeks of age ( Figures 5A and 5B) , the weaker synaptic depression following repetitive stimulation is thought to result from the increased number of vesicles available for release during enhanced activity. In contrast, the extent of synaptic depression was similar in wild-type and PCDH17 À/À mice at P16-P18 (Figure S6C) , suggesting that PCDH17's regulation of synaptic depression is developmental stage-dependent. Taken together, these electrophysiological data suggest that overall synaptic transmission efficacy is enhanced at anterior corticostriatal excitatory synapses in PCDH17 À/À mice.
PCDH17 -/-Mice Exhibit Antidepressant-like Behaviors
To examine behavioral abnormalities in PCDH17 À/À mice, we performed a battery of behavioral tests for evaluating sensory and motor functions, cognition, anxiety, and depression. We employed the tail suspension test and the forced swim test, which are widely used for assessing antidepressant-like activity in mice. In both tests, PCDH17 À/À mice were less immobile than wild-type mice ( Figures 7A and 7B ), suggesting that PCDH17 À/À mice were less susceptible to depression than wild-type mice. Alternatively, the reduced immobility of PCDH17 À/À mice in these tests might have been caused by an increase in spontaneous activity (Cryan and Holmes, 2005) . To check this possibility, we performed the open field test to measure showed that there were no significant differences between wildtype and PCDH17 À/À mice in terms of immobility time, total distance traveled, or the amount of rearing activity observed during the test (Figure 7C ), suggesting that spontaneous activity was normal in PCDH17 À/À mice. As alteration in fearfulness can also affect performance in tests for depression (Cryan and Holmes, 2005) , we also analyzed anxiety-related behavior. We did not detect any significant abnormalities in PCDH17 Figure S7 ). Collectively, PCDH17 À/À mice showed reduced susceptibility to depression, but other general behaviors, such as locomotor activity, anxiety behavior, fear learning, startle response, and pain behavior were normal.
PCDH17 Is Topographically Expressed in Corticobasal Ganglia Circuits of Primates
To better understand the possible functional role of PCDH17 in human depressive disorders, it is important to analyze its expression in primate brain. Here, we examined PCDH17 protein expression in corticobasal ganglia circuits of infant rhesus monkeys by immunostaining. Intense PCDH17 immunoreactivity was generally observed in the frontal lobe and the striatum, although the regional density differed among cortical areas or striatal sectors ( Figure 8A ). In the frontal lobe, PCDH17 signals were strong in the medial prefrontal cortex (area 32), the rostral part of the anterior cingulate cortex (area 24), and the medial part of the dorsolateral prefrontal cortex (area 9). PCDH17 signals were of intermediate strength in other prefrontal areas (such as areas 46 and 11) and the motor-related areas (such as areas 6 and 4). By contrast, PCDH17 immunoreactivity was weak in the other (parietal and temporal) cortical areas that include the somatosensory areas (areas 3 and 40) ( Figures 8A  and 8B ). Throughout the cortex, PCDH17 signals were apparent in layers V and VI ( Figure 8B ). Thus, cortical PCDH17 expression was rather specific to the frontal lobe, with a rostrocaudal gradient. Likewise, PCDH17 immunoreactivity in the striatum was found in both the caudate nucleus and the putamen with a clear rostrocaudal gradient ( Figure 8A ). In addition, PCDH17 expression occurred in the external and internal segments of the globus pallidus and the substantia nigra in a topographic manner ( Figure S8 ). These results indicate that the overall expression pattern of PCDH17 in primates is largely consistent with that in mice.
DISCUSSION
Topographically parallel organization is essential for information processing along corticobasal ganglia circuits. In this study, we showed that PCDH17 and PCDH10 display spatially complementary expression patterns along corticobasal ganglia circuits, suggesting that the expression of these protocadherins reflects the topographic organization of the pathway. Then, using PCDH17 À/À mice, we demonstrated that PCDH17 regulates presynaptic vesicle assembly and synaptic transmission efficacy in corticostriatal pathways. Finally, we found that PCDH17 À/À mice display less depression-like behavior, and that they manifested normal sensorimotor and cognitive functions and anxiety level, suggesting that PCDH17 is specifically involved in depressionrelated behavior. Based on neuroanatomical and neuroimaging studies in primates, an anteroposterior gradient of corticostriatal connections has been proposed (Draganski et al., 2008) . Specifically, neurons in prefrontal cortical areas, including the medial prefrontal cortex, project to anterior regions of the striatum, sensory, and motor cortical neurons to central dorsolateral regions, and parietal cortical neurons to more caudal regions, forming the limbic and associative loops, the sensorimotor loop, and the perceptual loop, respectively. Because PCDH17 was mostly expressed along the medial prefrontal cortex-anterior striatal pathways in a topographic manner, in both rodents and primates, it is likely that PCDH17 is anatomically and functionally conserved in the corticobasal ganglia circuits of higher primates as well. Therefore, the PCDH17-expressing neuronal pathway could correspond to the prefrontal cortical loops in primates used for processing some aspects of motivational and executive functions.
As the complementary expression patterns of PCDH17 and PCDH10 appear at E14.5 and gradually develop in the embryonic mouse striatum until birth (our unpublished data), we assumed that the expression of these protocadherins was reciprocally regulated by positional information in the embryonic striatum. Nevertheless, PCDH17 is dispensable in this topographic map formation ( Figure S4 ), although it has crucial roles in the synaptic development of this pathway. In addition to these protocadherins, some axon guidance molecules that are involved in topographic map formation in the visual and olfactory systems (Luo and Flanagan, 2007; Sakano, 2010) , are also expressed in the embryonic striatum in a zone-specific manner. Like PCDH17, Netrin-1 exhibits an expression pattern with a high-anterior to low-posterior gradient in embryonic striatal regions (Powell et al., 2008) . In contrast, similar to PCDH10, Ephrin-A5 and Semaphorin-3A exhibit expression patterns with low-anterior to high-posterior gradients (Dufour et al., 2003; Wright et al., 2007) . Therefore, these axon guidance molecules might organize the topographic map delineated by PCDH17 and PCDH10 expression in the embryonic basal ganglia. PCDH10 À/À mice exhibit axonal growth defects in the striatum and die within the first several weeks after birth (Uemura et al., 2007) , whereas PCDH17 À/À mice do not die prematurely and are not characterized by abnormal striatal axonal growth. These phenotypic differences may be at least partially attributable to different protein distributions in embryonic striatal fibers; PCDH10 (Uemura et al., 2007) , but not PCDH17 (our unpublished data), is distributed around striatal fibers at E14.5. It should be noted that similar to that of PCDH17, the expression of PCDH10 peaks during early synaptogenesis. A recent paper showed that PCDH10 is required for activity-dependent synapse elimination in cultured neurons (Tsai et al., 2012) . Therefore, PCDH10 may function not only in axonal growth, but also in synaptic development of corticobasal ganglia circuits. Conditional depletion of PCDH10 would be informative in elucidating its possible roles in synaptic development in that circuit. What are the molecular mechanisms by which PCDH17 regulates SV assembly in developmental synapses? One report showed that homophilic interactions of PCDH8, in cis or trans, decrease dendritic spine density (Yasuda et al., 2007) . Evidence that PCDH17 mediates intercellular homophilic interactions and is localized at perisynaptic sites may imply that homophilic interactions of PCDH17 regulate SV assembly in presynaptic terminals, although the cellular and molecular mechanisms need to be clarified. Several lines of evidence demonstrate that the N-cadherin-b-catenin adhesion complex plays a central role in recruiting SVs to presynaptic terminals (Arikkath and Reichardt, 2008) . SV clusters are surrounded by actin filaments, suggesting that localization of SVs is dependent upon F-actin (Bamji 2005) . Thus, the N-cadherin-b-catenin complex and its associated F-actin regulation are thought to play a part in presynaptic SV assembly. Given that some d-protocadherin members, such as PCDH8 and PCDH10, act as negative regulators of N-cadherin (Nakao et al., 2008; Yasuda et al., 2007) , it is likely that PCDH17 also perturbs the function of the N-cadherin-b-catenin complex and inhibits SV assembly forces. Furthermore, as the cytoplasmic domain of PCDH17, like that of PCDH10 and PCDH19, interacts with the WAVE complex (our unpublished data; Nakao et al., 2008; Tai et al., 2010) , PCDH17-WAVE complex machinery might affect the N-cadherin-b-catenin complex and its associated actin cytoskeleton, resulting in delocalization of SVs in presynaptic terminals. Further detailed analyses are required for clarification of the role of PCDH17 in SV assembly.
The abundance and localization of presynaptic SVs are critical for regulation of synaptic physiology. In N-cadherin and b-catenin knockout synapses, the response with respect to the EPSC amplitude during repetitive stimulation is significantly smaller, suggesting that the cadherin-catenin complex positively regulates the availability of SVs for release during high activity (Bamji et al., 2003; Jü ngling, et al., 2006) . Considering the possible negative regulation of N-cadherin by d-protocadherins (Nakao et al., 2008; Yasuda et al., 2007) , increased numbers of SVs in PCDH17 knockout synapses could contribute to the ready availability of SVs for neurotransmitter release. This idea is supported by our electrophysiological data that PCDH17 knockout synapses exhibited less synaptic depression following repetitive stimulation of input fibers. It is assumed that paired-pulse depression is affected by SV transitions in the pools as well as by neurotransmitter release probability (Regehr, 2012) . It might be possible that PCDH17 deficiency decreases paired-pulse depression as a result of higher vesicle replenishment into release sites. Although it is also possible that the presynaptic release probability is changed at PCDH17 knockout synapses, the precise roles of PCDH17 in presynapses need to be analyzed in future studies. In addition to its regulatory role in presynaptic function, PCDH17 may have additional roles in postsynaptic function considering the both pre-and postsynaptic localization of PCDH17.
Our observation that loss of PCDH17 affects depressionrelated behaviors might suggest that altered synaptic function in the aforementioned PCDH17-expressing corticobasal ganglia circuits could play an important role in depressive behaviors. Accordingly, dysregulated functional activity within an extended network, including medial prefrontal cortex and striatum, is a key symptom of depression in humans (Krishnan and Nestler, 2008; Price and Drevets, 2012) . Optogenetic stimulation of the medial prefrontal cortex-mediated pathways in rodents is reported to control depression-related behaviors (Covington et al., 2010; Warden et al., 2012) . Furthermore, our hypothesis may be supported by evidence that PCDH17 is strongly expressed in the primate prefrontal cortical area and associated regions that are most crucial for depression. Although PCDH17 was also expressed in amygdala, hypothalamus, and other mesolimbic areas, future studies with neural pathway-specific PCDH17 conditional knockout mice could clarify the possible relationship between topographic corticobasal ganglia circuits and depression-related behaviors. Moreover, it will be of considerable importance to search for mutations in PCDH17 in human mood disorders.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Information. Experiments were conducted according to the institutional ethical guidelines for animal experiments.
Generation of PCDH17 -/-Mice
Details can be found in Supplemental Experimental Procedures.
Intracranial Surgery
Intracranial surgery was performed as previously described (Fukabori et al., 2012) . Cell Culture, DNA Transfection, Stable Transfectants, Coculture Experiments, and Immunocytochemistry Neuronal culture was performed as previously described . Details can be found in Supplemental Experimental Procedures.
Fc Pull-Down Assay
The Fc pull-down assay was performed as previously described (Kazmierczak et al., 2007) .
Histology X-gal staining, fluorescent in situ hybridization, immunohistochemistry, STORM imaging, pre-embedding immunogold electron microscopy, Nissl staining, and immunohistochemistry in rhesus monkey brain were basically performed as described (Dani et al., 2010; Lu et al., 2012; Takeuchi et al., 2010; Taniguchi et al., 2009; Yamasaki et al., 2010) .
Time-Lapse Live Imaging
Time-lapse imaging analysis was performed as previously described (Oshimori et al., 2009 ).
Electron Microscopy
Transmission electron microscopy analysis was performed as previously described (Goto et al., 2008) . Electrophysiology Whole-cell patch-clamp recordings were performed as previously described (Tanimura et al., 2010) .
Behavioral Tests
All behavioral experiments were performed as blind tests. Male mice, 7-9 weeks of age, were analyzed for all experiments as previously described (Taniguchi et al., 2009 ).
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, two movies, and Supplemental Experimental Procedures and can be found with this article online at http://dx.doi.org/10.1016/j.neuron.2013.03.031.
